Trial Profile
An Open-Label Multicentre Study of Anakinra (Kineret) in Combination With DMARDS in Subjects With Active Rheumatoid Arthritis (RA)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 07 Jun 2012 New trial record